Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

VIGL Vigil Neuroscience Inc

1,63

0,05 (3,16%)

24 Déc 2024 - Fermé

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/19/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Christopher John Verni

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Vigil Neuroscience (NASDAQ:VIGL)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024

Plus de graphiques de la Bourse Vigil Neuroscience

Vigil Neuroscience (NASDAQ:VIGL)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024

Plus de graphiques de la Bourse Vigil Neuroscience

Actualités Vigil Neuroscience Inc

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 20 Décembre 2024 ( il y a 6 jours) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jeudi 14 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Vigil Neuroscience to Present at Upcoming Investor Conferences
Mardi 12 Novembre 2024 ( il y a 1 mois) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jeudi 7 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Jeudi 7 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business Update
Jeudi 7 Novembre 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Vigil Neuroscience to Present at Guggenheim Healthcare Innovation Conference
Mardi 5 Novembre 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Jeudi 10 Octobre 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jeudi 19 Septembre 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Mardi 17 Septembre 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927
Mardi 17 Septembre 2024 ( il y a 3 mois) • GlobeNewswire Inc.

Vigil Neuroscience to Present at Cantor Global Healthcare Conference
Lundi 16 Septembre 2024 ( il y a 3 mois) • GlobeNewswire Inc.

Plus d'articles sur Vigil Neuroscience Inc

Credit Agricole

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales